Showing results (571-580 of 673) with videos related to
Sort By:
Pageof 68
HIV Clinical Trials|February 11, 2003
Sequencing to NRTI plus NNRTI-only combinations after virological failure of protease inhibitor-based combination HIV-1 therapyD Asboe, S Mandalia, B G GazzardHIV Clinical Trials|February 11, 2003
Comparison of metabolic abnormalities and clinical lipodystrophy 48 weeks after switching from HAART to Trizivir versus continued HAART: the Trizal studyAlain Lafeuillade, Nathan Clumeck, Josep Mallolas, et al.HIV Clinical Trials|February 11, 2003
Centralized assessment of dual-energy X-ray absorptiometry (DEXA) in multicenter studies of HIV-associated lipodystrophyDon E Smith, Jeff Hudson, Allison Martin, et al.HIV Clinical Trials|April 3, 2003
Variable virological outcomes according to the center providing antiretroviral therapy within the PharmAdapt clinical trialP Clevenbergh, M C Bozonnat, M Kirstetter, et al.HIV Clinical Trials|April 3, 2003
Incidence of liver injury after beginning antiretroviral therapy with efavirenz or nevirapineLuz Martín-Carbonero, Marina Núñez, Juan González-Lahoz, et al.HIV Clinical Trials|April 3, 2003
Efficacy of an educational and counseling intervention on adherence to highly active antiretroviral therapy: French prospective controlled studyChristian Pradier, Laurence Bentz, Bruno Spire, et al.HIV Clinical Trials|August 14, 2003
Placebo practice trials: the best predictor of adherence readiness for HAART among drug users?Glenn WagnerHIV Clinical Trials|August 2, 2006
HIV pharmacology: barriers to the eradication of HIV from the CNSBryan McGee, Nathalie Smith, Francesca AweekaHIV Clinical Trials|June 27, 2006
Tenofovir-containing nucleoside/nucleotide-only antiretroviral maintenance therapy: decision making and virological outcomeManuela Buehlmann, Jean-Philippe Chave, Markus Flepp, et al.HIV Clinical Trials|May 18, 2007
Modelling-based prediction of clinical benefits from etravirine in the TMC125-C223 trialAndrew Hill, Howard Grossman, Cal Cohen, et al.Pageof 68